NCT00136175View on ClinicalTrials.gov

Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

December 31, 2005

Study Completion Date

October 31, 2007

Conditions

Bladder Cancer

Interventions

DRUG

Paclitaxel

DRUG

Carboplatin

DRUG

Gemcitabine

Trial Locations (1)

48109

The University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors

lead

University of Michigan Rogel Cancer Center

OTHER

NCT00136175 - Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder | Biotech Hunter | Biotech Hunter